TY - JOUR
T1 - Smoking cessation services and shared decision-making practices among lung cancer screening facilities
T2 - A cross-sectional study
AU - Lowenstein, Lisa M.
AU - Nishi, Shawn P.E.
AU - Lopez-Olivo, Maria A.
AU - Crocker, Laura Covarrubias
AU - Choi, Noah
AU - Kim, Bumyang
AU - Shih, Ya Chen “Tina”
AU - Volk, Robert J.
N1 - Funding Information:
Lisa M. Lowenstein reports funding from the Health Care Service Corporation through Blue Cross Blue Shield of Texas. Maria A. Lopez‐Olivo reports funding from the National Cancer Institute (K08 CA237619), an Investigator Award from the Rheumatology Research Foundation, and consulting fees from the American Cancer Society. Ya‐Chen “Tina” Shih reports funding from the Alliance Foundation, the National Cancer Institute (R01CA225646 and R01CA225647), and the Health Care Service Corporation through Blue Cross Blue Shield of Texas; consulting fees, travel support, and accommodations for serving on a grant review panel for Pfizer, Inc, and an advisory board for AstraZeneca (both in 2019 and both unrelated to the content of this article); and serving as a member of the American Cancer Society Guideline Development Group. The other authors made no disclosures.
Funding Information:
This study was supported by grants from the Cancer Prevention and Research Institute of Texas (RP190210 and RP160674), the The University of Texas MD Anderson Cancer Center Cancer Center Support Grant funded by the National Cancer Institute (P30CA016672) using the Shared Decision Making Core and Clinical Protocol and Data Management System, a grant from the Boone Pickens Distinguished Chair for Early Prevention of Cancer to Ernest Hawk and The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment, and a research grant funded by the National Cancer Institute (R01 CA207216).
Publisher Copyright:
© 2022 American Cancer Society.
PY - 2022/5/15
Y1 - 2022/5/15
N2 - Background: Little is known about how screening facilities are meeting the requirements for the reimbursement of lung cancer screening from the Centers for Medicare & Medicaid Services (CMS), including 1) the collection and submission of data to the CMS-approved registry (American College of Radiology [ACR] Lung Cancer Screening Registry), 2) the verification of a counseling and shared decision-making (SDM) visit having occurred as part of the written order for lung cancer screening with low-dose computed tomography, and 3) the offering of smoking cessation interventions. Methods: The authors identified facilities in a southwestern state that were listed by either the ACR Lung Cancer Screening Registry or the GO2 Foundation Centers of Excellence. To select facilities, they used 2 purposive sampling approaches: maximum variation sampling and snowball sampling. They surveyed facilities from February to November 2019. Results: There were 87 facilities contacted, and a total of 63 facilities representing 32 counties across Texas completed the survey. Nearly all facilities used Lung-RADS to classify nodules (92%; n = 58) and submitted data to a CMS-approved registry (92%; n = 57). Most facilities verified that the counseling and SDM visit had occurred (86%; n = 54). Although slightly more than half of the facilities reported always providing self-help cessation materials (68%; n = 42), similar or higher proportions of facilities reported that they never referred smokers to onsite cessation services (68%; n = 42) or quitlines (77%; n = 47), provided cessation counseling (81%; n = 50), or recommended medications (85%; n = 52). Conclusions: In general, screening facilities are meeting CMS requirements for screening, but they are struggling to offer smoking cessation interventions other than providing self-help materials.
AB - Background: Little is known about how screening facilities are meeting the requirements for the reimbursement of lung cancer screening from the Centers for Medicare & Medicaid Services (CMS), including 1) the collection and submission of data to the CMS-approved registry (American College of Radiology [ACR] Lung Cancer Screening Registry), 2) the verification of a counseling and shared decision-making (SDM) visit having occurred as part of the written order for lung cancer screening with low-dose computed tomography, and 3) the offering of smoking cessation interventions. Methods: The authors identified facilities in a southwestern state that were listed by either the ACR Lung Cancer Screening Registry or the GO2 Foundation Centers of Excellence. To select facilities, they used 2 purposive sampling approaches: maximum variation sampling and snowball sampling. They surveyed facilities from February to November 2019. Results: There were 87 facilities contacted, and a total of 63 facilities representing 32 counties across Texas completed the survey. Nearly all facilities used Lung-RADS to classify nodules (92%; n = 58) and submitted data to a CMS-approved registry (92%; n = 57). Most facilities verified that the counseling and SDM visit had occurred (86%; n = 54). Although slightly more than half of the facilities reported always providing self-help cessation materials (68%; n = 42), similar or higher proportions of facilities reported that they never referred smokers to onsite cessation services (68%; n = 42) or quitlines (77%; n = 47), provided cessation counseling (81%; n = 50), or recommended medications (85%; n = 52). Conclusions: In general, screening facilities are meeting CMS requirements for screening, but they are struggling to offer smoking cessation interventions other than providing self-help materials.
KW - early detection
KW - health care delivery
KW - lung neoplasms
KW - shared decision-making
KW - smoking cessation
UR - http://www.scopus.com/inward/record.url?scp=85124510123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124510123&partnerID=8YFLogxK
U2 - 10.1002/cncr.34145
DO - 10.1002/cncr.34145
M3 - Article
C2 - 35157302
AN - SCOPUS:85124510123
SN - 0008-543X
VL - 128
SP - 1967
EP - 1975
JO - Cancer
JF - Cancer
IS - 10
ER -